2016 Partners

The Medicine Maker is a global magazine focused on the development and manufacture of both pharmaceutical and biopharmaceutical products. Our editorial style is practical, pragmatic and meaningful to the daily working life of all professionals in the clinical, regulatory, development and manufacturing fields.

It helps professionals to do their job better.  Feature articles tell the stories behind the biggest concepts, innovations, challenges and advances in the field.

Manufacturing Chemist is established and respected in the global pharmaceutical industry.
Published by HPCi Media, daily, weekly and monthly through its web and print options, all products work together to give you the insight and foresight to aid planning and decision making.

SCIAD Newswire is a news distribution business for the life science, biotech and healthcare sectors. We distribute our customers’ news to editors, reporters and social media influencers worldwide who write about healthcare, biotech and life science.

We founded Sciad Newswire after recognising that companies wanting to make media announcements required an alternative to full service PR agencies. We communicate closely with journalists and PR professionals to gain feedback and maintain high quality standards.

With more than 20 years’ experience working in healthcare and science communications we have unique and unrivalled databases of contacts who want to read and publish new developments for their readers.

Citigate Dewe Rogerson’s Life Sciences team is wholly dedicated to the sector and has exceptional industry knowledge allied to proven backgrounds in communications, capital markets, journalism and science. This expertise and experience has enabled us to become long-term, trusted advisors to some of the most innovative and exciting life sciences companies in the UK and Europe.

Our clients are at all stages of development, from start-up to multi-nationals, and our activities are focused on delivering campaigns that support corporate objectives. We judge our success by our clients’ success, and we are proud to have worked on many of the most significant transactions and events in the life science sector over the past decade.

Stevenage Bioscience Catalyst (SBC) opened as the UK’s first open innovation biomedical campus in 2012, and combines a unique blend of infrastructure and virtual networks to drive collaboration. Backed by a unique partnership between Government, GlaxoSmithKline and the Wellcome Trust, the remit was, and remains, to catalyse innovation for patient benefit in a phased development. SBC has a strong commitment to companies that focus on high quality science and share its vision, and its development of activity clusters and direct access to the expertise of a major pharmaceutical company are among its unique characteristics.

There is start-up and grow-on space for companies, plus a commercially focused management team viewed as a leader in UK incubation. With Phase 1 at capacity, Phase 2 is in development for the continuation of the collaborative vision, with a focus on convergent medical technologies. Co-located with GlaxoSmithKline in Stevenage, Stevenage Bioscience Catalyst is located close to both London and Cambridge.

For more information, please go to www.stevenagecatalyst.com.

De Facto is a full-service agency with an international reach providing specialist communications consulting to the healthcare and life science sectors. With 30-years experience in science, health and global media relations, digital, branding and marketing services, De Facto’s clients include the industry’s biggest players from the pharma, biotech and CMO/CRO sectors right through to start-ups and university spin outs.

The agency’s USPs remain its market knowledge, contacts, strategic insights and the ability to turn this into engaging copy for the global life sciences media. Our strong relationships with our clients, industry leaders and significantly, the media, ensure that we consistently deliver the most successful, well covered and impactful campaigns.

Exceptional science, strategy and communication, from bench to boardroom to broadcast.

We support our Clients by navigating through technical challenges, translating data into strategy and communication, and revealing the impact of their science.